{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:26:27Z","timestamp":1779207987915,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"am","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["T32AA007456"],"award-info":[{"award-number":["T32AA007456"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA050311"],"award-info":[{"award-number":["UH3DA050311"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["F31DA054796"],"award-info":[{"award-number":["F31DA054796"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30DA033934"],"award-info":[{"award-number":["P30DA033934"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jpet.2025.103717","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:31:35Z","timestamp":1758299495000},"page":"103717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fixed-proportion mixtures with the \u03b12-adrenergic agonist clonidine or lofexidine do not alter fentanyl self-administration in non\u2013opioid-dependent male and female rats"],"prefix":"10.1016","volume":"392","author":[{"given":"Allison","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-7118","authenticated-orcid":false,"given":"Celsey M.","family":"St. Onge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4949-5246","authenticated-orcid":false,"given":"Matthew L.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103717_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: a growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.jpet.2025.103717_bib4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/ADM.0000000000001216","article-title":"Self-reported xylazine experiences: a mixed-methods study of reddit subscribers","volume":"17","author":"Spadaro","year":"2023","journal-title":"J Addict Med"},{"issue":"5","key":"10.1016\/j.jpet.2025.103717_bib5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/ajad.70030","article-title":"Rise of illicit medetomidine use: a worrisome trend","volume":"34","author":"Sood","year":"2025","journal-title":"Am J Addict"},{"issue":"15","key":"10.1016\/j.jpet.2025.103717_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.15585\/mmwr.mm7415a1","article-title":"Overdoses involving medetomidine mixed with opioids - Chicago, Illinois, May 2024","volume":"74","author":"Nham","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpet.2025.103717_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/jat\/bkaf040","article-title":"Medetomidine quantitation and enantiomer differentiation in biological specimens collected after fatal and non-fatal opioid overdoses","author":"Walton","year":"2025","journal-title":"J Anal Toxicol"},{"issue":"22","key":"10.1016\/j.jpet.2025.103717_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183354","article-title":"Xylazine induces dopamine release and augments the effects of fentanyl","volume":"134","author":"Trinko","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpet.2025.103717_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109816","article-title":"Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: a comparison to lofexidine","volume":"245","author":"Sadek","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpet.2025.103717_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111282","article-title":"Xylazine does not enhance fentanyl reinforcement in rats: a behavioral economic analysis","volume":"258","author":"St. Onge","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.jpet.2025.103717_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00436094","article-title":"Reinforcing properties of clonidine in rhesus monkeys","volume":"77","author":"Woolverton","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.jpet.2025.103717_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0376-8716(98)00130-6","article-title":"Evaluation of the intravenous reinforcing effects of clonidine in baboons","volume":"53","author":"Weerts","year":"1999","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.jpet.2025.103717_bib13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0024-3205(77)90391-5","article-title":"Catecholaminergic mechanisms of reinforcement: direct assessment by drug self-administration","volume":"20","author":"Davis","year":"1977","journal-title":"Life Sci"},{"key":"10.1016\/j.jpet.2025.103717_bib14","first-page":"259","article-title":"Self-administration of clonidine by the rat","volume":"71","author":"Shearman","year":"1981","journal-title":"Prog Clin Biol Res"},{"issue":"7","key":"10.1016\/j.jpet.2025.103717_bib15","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0006-2952(97)00631-X","article-title":"Ligand efficacy and potency at recombinant \u03b12 adrenergic receptors: agonist-mediated [35s]gtp\u03b3s binding","volume":"55","author":"Jasper","year":"1998","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2025.103717_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0304-3940(80)90172-X","article-title":"Selectivity of a series of clonidine-like drugs for \u03b11 and \u03b12 adrenoceptors in rat brain","volume":"20","author":"Summers","year":"1980","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpet.2025.103717_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176863","article-title":"The Mitragyna speciosa (kratom) alkaloid mitragynine: analysis of adrenergic \u03b12 receptor activity in vitro and in vivo","volume":"980","author":"Obeng","year":"2024","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.jpet.2025.103717_bib18","article-title":"Alpha(2)-adrenergic agonists for the management of opioid withdrawal","volume":"2016","author":"Gowing","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.jpet.2025.103717_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.japh.2019.10.004","article-title":"Lofexidine versus clonidine for mitigation of opioid withdrawal symptoms: a systematic review","volume":"60","author":"Kuszmaul","year":"2020","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.jpet.2025.103717_bib20","article-title":"Preclinical determinants of drug choice under concurrent schedules of drug self-administration","volume":"2012","author":"Banks","year":"2012","journal-title":"Adv Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.jpet.2025.103717_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1037\/0033-295X.115.1.186","article-title":"Economic demand and essential value","volume":"115","author":"Hursh","year":"2008","journal-title":"Psychol Rev"},{"issue":"2","key":"10.1016\/j.jpet.2025.103717_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1037\/1064-1297.9.2.131","article-title":"Regulation of drug intake","volume":"9","author":"Lynch","year":"2001","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103717_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1976.tb27919.x","article-title":"Interactions of behavioral effects of drugs","volume":"281","author":"Dews","year":"1976","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.jpet.2025.103717_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1749-6632.1976.tb27920.x","article-title":"Behavioral methods for the study of drug interactions","volume":"281","author":"Schuster","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jpet.2025.103717_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2021.109110","article-title":"A drug-vs-food \u201cchoice\u201d self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disorders","volume":"354","author":"Townsend","year":"2021","journal-title":"J Neurosci Methods"},{"issue":"12","key":"10.1016\/j.jpet.2025.103717_bib26","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/s41386-019-0356-1","article-title":"Sex differences in opioid reinforcement under a fentanyl vs. food choice procedure in rats","volume":"44","author":"Townsend","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.jpet.2025.103717_bib27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/0091-3057(82)90122-8","article-title":"Self-stimulation response decrement patterns differentiate clonidine, baclofen and dopamine antagonists from drugs causing performance deficit","volume":"17","author":"Fenton","year":"1982","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"10.1016\/j.jpet.2025.103717_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/clpt.1985.162","article-title":"Self-administration of clonidine, oxazepam, and hydromorphone by patients undergoing methadone detoxification","volume":"38","author":"Preston","year":"1985","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jpet.2025.103717_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1124\/jpet.107.123042","article-title":"Drug and reinforcement history as determinants of the response-maintaining effects of quinpirole in the rat","volume":"323","author":"Collins","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2025.103717_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/adb.12120","article-title":"Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia","volume":"20","author":"Park","year":"2015","journal-title":"Addict Biol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103717_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/jpet.120.266007","article-title":"Effects of the alpha-2 adrenergic receptor agonist lofexidine on food-cocaine choice in socially housed cynomolgus monkeys","volume":"375","author":"Czoty","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.jpet.2025.103717_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.drugalcdep.2013.07.032","article-title":"Differential effects of acute and chronic treatment with the \u03b12-adrenergic agonist, lofexidine, on cocaine self-administration in rhesus monkeys","volume":"133","author":"Kohut","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpet.2025.103717_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.addicn.2024.100155","article-title":"Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism","volume":"11","author":"Bedard","year":"2024","journal-title":"Addict Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:58:26Z","timestamp":1761850706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525402304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0022356525402304"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103717","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fixed-proportion mixtures with the \u03b12-adrenergic agonist clonidine or lofexidine do not alter fentanyl self-administration in non\u2013opioid-dependent male and female rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103717"}}